Value-based payment models and management of newly diagnosed prostate cancer.
Avinash MagantySamuel R KaufmanMary K OerlineKassem S FarajMegan E V CaramVahakn B ShahinianBrent K HollenbeckPublished in: Cancer medicine (2023)
How urologists participate in value-based payment models is not associated with treatment, potential overtreatment, and prostate cancer spending in men with newly diagnosed disease.